SCHEMBL6538538

SCHEMBL6538538

C=Cc1ccnc2c(N)cccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.45
NR4A2 P43354 1/20 0.43
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
ALDH1A1 P00352 2/20 0.42
MAPT P10636 2/20 0.42
APAF1 O14727 1/20 0.42
TDP2 O95551 1/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
CCR1 P32246 1/20 0.40
CCR5 P51681 1/20 0.40
CCR8 P51685 1/20 0.40
HSP90AA1 P07900 4/20 0.39
HSP90AB1 P08238 3/20 0.39
TDP1 Q9NUW8 2/20 0.37
CYP3A4 P08684 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23760627 0.82 CCR1 (0.63) PARP1NR4A2MEN1KMT2AALDH1A1
SCHEMBL28165057 0.79 HTR1A (0.51) PARP1MEN1KMT2ACCR1CCR5
SCHEMBL10985905 0.78 CCR1 (0.61) MEN1KMT2AALDH1A1CCR1CCR5
SCHEMBL30357769 0.78 CCR1 (0.42) NR4A2KMT2AALDH1A1MAPTCCR1
SCHEMBL6629560 0.77 NR4A2 (0.68) PARP1NR4A2MEN1KMT2AALDH1A1
SCHEMBL30668493 0.77 NR4A2 (0.68) PARP1NR4A2MEN1KMT2AALDH1A1
Formamide SCHEMBL9730893 0.76 KDM4E (0.53) MEN1KMT2AALDH1A1MAPTCCR1
SCHEMBL11904257 0.75 PARP1 (0.49) PARP1MEN1KMT2ACCR1CCR5
SCHEMBL23760623 0.74 HTR1A (0.38) MEN1KMT2AALDH1A1MAPTCCR1
SCHEMBL11888289 0.74 CCR1 (0.43) MEN1KMT2AALDH1A1MAPTCCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed